O'Shaughnessy Asset Management, LLC Enanta Pharmaceuticals Inc Transaction History

O'Shaughnessy Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$60.08 - $88.17 $243,864 - $357,882	-4,059 Closed	0 $0
Q2 2019 Aug 07, 2019	SELL	$81.3 - $97.35 $574,872 - $688,361	-7,071 Reduced 63.53%	4,059 $341,000
Q1 2019 May 10, 2019	SELL	$69.08 - $105.66 $1.04 Million - $1.59 Million	-15,013 Reduced 57.43%	11,130 $0
Q4 2018 Feb 12, 2019	SELL	$65.41 - $84.65 $371,725 - $481,065	-5,683 Reduced 17.86%	26,143 $1.85 Million
Q3 2018 Nov 06, 2018	BUY	$85.46 - $126.37 $769 - $1,137	9 Added 0.03%	31,826 $2.7 Million
Q2 2018 Aug 10, 2018	BUY	$81.85 - $120.51 $398,282 - $586,401	4,866 Added 18.05%	31,817 $3.67 Million
Q1 2018 May 08, 2018	BUY	$57.91 - $92.15 $1.23 Million - $1.96 Million	21,310 Added 377.77%	26,951 $2.18 Million
Q4 2017 Feb 13, 2018	BUY	$45.65 - $59.37 $257,511 - $334,906	5,641	5,641 $331,000

107

21.2M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $102M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.